DCGI approves market authorisation for Covovax as Covid booster dose

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or......

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. IMAGE: Kindly......

Parl panel advises caution in emergency approval of vaccine

Any vaccine against COVID-19 should be granted emergency use authorisation only after proper consideration and conducting its trials on a sufficient sample size, a parliamentary panel chaired by......

India gets 3rd vaccine as DCGI approves Sputnik V

India's drug regulator has granted permission for the restricted emergency use of Russian COVID-19 vaccine 'Sputnik V' with certain conditions, paving the way for a third vaccine to be available in......